ZYVERSA THERAPEUTICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.94 USD | +21.08% |
|
+14.62% | -45.11% |
Chart calendar ZyVersa Therapeutics, Inc.
3c2b177e4425767.rjzQqwikG_repKr7ai4ftpM4URLipzdVPLvZSayiVQs._Xi82VfAdpes5dCJKRxY5MZ2JX6FzmNhUsm8LP-XYFPsSaicXNUvkKqUmg~b55aeacfffbd76809ddd9512ba992ce9
Upcoming events on ZyVersa Therapeutics, Inc.
Past events on ZyVersa Therapeutics, Inc.
| 2024-05-15 08:35 | Q1 2024 Earnings Release |
| 2024-04-16 | Extraordinary Shareholders Meeting |
| 2024-03-25 08:17 | Q4 2023 Earnings Release |
| 2024-03-20 13:30 | Benzinga Virtual Healthcare Summit |
| 2024-02-26 10:30 | BIO CEO & Investor Conference |
| 2023-11-14 16:35 | Q3 2023 Earnings Release |
| 2023-10-30 | Annual General Meeting |
| 2023-10-12 10:30 | BioFlorida Conference |
| 2023-08-21 16:15 | Q2 2023 Earnings Release |
| 2023-07-25 10:00 | H.C. Wainwright Kidney Conference |
| 2023-06-04 | BIO International Convention |
| 2023-05-22 | A.G.P Virtual Healthcare Conference |
| 2023-05-12 09:07 | Q1 2023 Earnings Release |
| 2023-05-10 09:15 | Sidoti Micro-Cap Virtual Conference |
| 2023-04-26 17:00 | Planet Microcap Showcase |
| 2023-04-03 09:05 | Q4 2022 Earnings Release |
| 2023-03-14 17:00 | Roth Conference |
| 2023-03-13 11:20 | Oppenheimer Healthcare Conference |
| 2023-02-06 14:45 | BIO CEO and Investor Conference |
| 2023-01-26 11:30 | J.P.Morgan Healthcare Conference |
Annual results
| Fiscal Period | December | 2022 | 2023 | 2024 |
|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 |
|
EBITDA | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -108 -97,2 -10.92% | -16,4 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -14,9 | -108 -97,1 -10.92% | -16,4 |
|
Net income Million USD | Released Forecast Spread | 0,00 | -106 -88,3 -20.32% | -16,4 |
|
EPS USD | Released Forecast Spread | -347 | -1 090 -711 -53.21% | -15,1 |
| Announcement Date | 31/03/23 | 25/03/24 | - |
Quarterly results
| Fiscal Period | December | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -2,90 -6,00 51.62% | -13,9 -3,33 -318.45% | -2,83 -3,72 24.02% | -3,85 | -4,19 | -4,60 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -2,90 -6,00 51.62% | -13,9 -3,33 -318.46% | -2,83 -3,72 24.01% | -3,85 | -4,19 | -4,60 |
|
Net income Million USD | Released Forecast Spread | -2,93 -6,00 51.09% | -13,3 -3,33 -300.56% | -2,83 -3,72 24.01% | -3,85 | -4,19 | -4,60 |
|
EPS USD | Released Forecast Spread | -31,5 -56,0 43.75% | -1 042 -21,4 -4768.22% | -4,53 -3,70 -22.43% | -3,75 | -3,70 | -4,05 |
| Announcement Date | 14/11/23 | 25/03/24 | 15/05/24 | - | - | - |
More events
Past sector events for ZyVersa Therapeutics, Inc.
| 2024-05-17 07:00 | AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release |
| 2024-05-16 07:46 | BIOCON LIMITED: Q4 2024 Earnings Release |
| 2024-05-16 01:00 | ZEALAND PHARMA A/S: Q1 2024 Earnings Release |
| 2024-05-15 | LIGACHEM BIOSCIENCES INC.: Q1 2024 Earnings Release |
| 2024-05-15 08:05 | THIRD HARMONIC BIO, INC.: Q1 2024 Earnings Release |
| 2024-05-15 07:00 | CABALETTA BIO, INC.: Q1 2024 Earnings Release |
| 2024-05-14 | TAIMED BIOLOGICS INC.: Q1 2024 Earnings Release |
| 2024-05-14 16:05 | ENLIVEN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-05-14 16:00 | ARCUTIS BIOTHERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-05-14 08:00 | IMMUNOME, INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- ZVSA Stock
- Calendar ZyVersa Therapeutics, Inc.
